About US
Contact us
-
Actelion's PAH drug Opsumit now available in EnglandActelion Pharmaceuticals UK has launched Opsumit (macitentan), which is now available on prescription in England as a new treatment option for patients with pulmonary arterial hypertension (PAH). PAH2014/5/19
-
FDA to review Teva's sNDA for pediatric indication of QNASL nasal aerosolThe US Food and Drug Administration (FDA) will review Israel-based Teva Pharmaceuticals' supplemental new drug application (sNDA) for a lower dose QNASL nasal aerosol indicated for treatment of season2014/5/19
-
ILE Pharmaceutical Materials Co. sincerely invites you to visit CPhI, ICSE & BioPh China 2014Date: June 26th – 28thAddress: Shanghai New International Expo Center , 2014( No. 2345 Longyang Road, Pudong District, Shanghai)ILE Stand No.: E1E20 Our technical staff will be at the show site to sh2014/5/16
-
U.K. court cuts Alimta exclusivity short, threatening Lilly's European salesEli Lilly ($LLY) might have succeeded in protectingAlimtafrom generics in the U.S., but in the U.K.? Not so much. Lilly lost a patent fight with Actavis ($ACT) in English High Court, in a ruling that2014/5/16
-
Sanofi hopes to make a splash with new meningitis vax initiativeAccording to a new survey, more than two-thirds of mothers have little to no knowledge of the CDC's recommendations for preventing meningococcalmeningitis. And if you're a meningitisvaccinemaker like2014/5/15
-
China speaks on GSK bribery charges, and the word isn't goodChina is coming down hard on GlaxoSmithKline's ($GSK) local operation. After a months-long bribery probe,Chinesepolice have slapped Glaxo's former country chief--Mark Reilly, a Brit--and two other top2014/5/15
-
Akorn agrees to buy VersaPharmUS-based Akorn has entered into a definitive agreement to acquire VPI Holdings, the parent company of VersaPharm, for $440m in cash. The privately held developer and marketer of multi-source prescrip2014/5/14
-
Bayer's Kogenate FS gets FDA approval for routine prophylaxis in Hemophilia A patientsBayer HealthCare has received approval from the US Food and Drug Administration (FDA) for a new indication of its Kogenate FS antihemophilic factor VIII (recombinant), for routine prophylaxis to preve2014/5/14
-
AbbVie seeks EMA approval for marketing interferon-free hepatitis C therapy in EUUS-based biopharmaceutical firm AbbVie has submitted marketing authorisation applications (MAAs) to the European Medicines Agency (EMA) seeking approval for its investigational, all-oral, interferon-f2014/5/13
-
GSK and Theravance announce European approval for chronic obstructive pulmonary disease drugGlaxoSmithKline (GSK) and Theravance have announced the European Commission's marketing approval for Anoro (umeclidinium/vilanterol) for the treatment of chronic obstructive pulmonary disease (COPD).2014/5/13